Journal of Hospital Infection, volume 111, pages 180-183
Comparison of the in-vitro efficacy of different mouthwash solutions targeting SARS-CoV-2 based on the European Standard EN 14476
Katrin Steinhauer
1
,
Toni L. Meister
2
,
Daniel Todt
3
,
Adalbert Krawczyk
4
,
L Paßvogel
5
,
B Becker
6
,
D Paulmann
6
,
B Bischoff
6
,
Stephanie Pfaender
2
,
Florian H.H. Brill
6
,
Eike Steinmann
2
4
5
Department of Research & Scientific Services, Schülke & Mayr GmbH, Norderstedt, Germany
|
6
Dr. Brill + Partner GmbH Institute for Hygiene and Microbiology, Hamburg, Germany
|
Publication type: Journal Article
Publication date: 2021-05-01
Journal:
Journal of Hospital Infection
scimago Q1
SJR: 1.095
CiteScore: 12.7
Impact factor: 3.9
ISSN: 01956701, 15322939
General Medicine
Microbiology (medical)
Infectious Diseases
Abstract
Summary
The outbreak of the SARS-CoV-2 pandemic is triggering a global health emergency alert. Until vaccination becomes available, a bundle of effective preventive measures is desperately needed. Recent research is indicating the relevance of aerosols in the spread of SARS-CoV-2. Thus, in this study commercially available antiseptic mouthwashes based on the active ingredients chlorhexidine digluconate and octenidine dihydrochloride (OCT) were investigated regarding their efficacy against SARS-CoV-2 using the European Standard 14476. Based on the requirement of EN 14476 in which reduction of at least four decimal logarithms (≥4 log10) of viral titre is requested to state efficacy, the OCT-based formulation was found to be effective within a contact time of only 15 s against SARS-CoV-2. Based on this in-vitro data the OCT mouthwash thus constitutes an interesting candidate for future clinical studies to prove its effectiveness in a potential prevention of SARS-CoV-2 transmission by aerosols.Nothing found, try to update filter.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.